Target intelligence / Profile preview

High mobility group box 3 pseudogene 13 (HMGB3P13)

Target
HMGB3P13
Molecular classification
Other (Pseudogene)
01

Overview

High mobility group box 3 pseudogene 13 (HMGB3P13) is a segment of DNA that resembles the functional high mobility group box 3 (HMGB3) gene but is nonfunctional, presumed to have lost its protein-coding ability due to accumulated mutations. Pseudogenes like HMGB3P13 are typically regarded as genomic fossils and do not produce functional proteins. Most pseudogenes, including HMGB3P13, are not considered therapeutic targets, enzymes, receptors, or otherwise "druggable" molecules. While some pseudogenes in general can regulate gene expression through RNA-mediated mechanisms or serve as disease biomarkers, there is currently no specific evidence supporting any such function for HMGB3P13. It is not referenced as a therapeutic target in scientific or medical literature.

Other names
HMGB3 pseudogene 13
02

Mechanism of action

None known; pseudogenes may act as RNA decoys or regulators, but HMGB3P13 has no evidence for such a role

03

Biological functions

Other (does not encode a functional protein; may have regulatory RNA roles in general pseudogene context, but none specifically proven for HMGB3P13)
04

Disease associations

Other (no direct evidence for disease involvement of HMGB3P13 specifically; some pseudogenes can be implicated in disease regulation, but none are known for this pseudogene)

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 13 (HMGB3P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 13 (HMGB3P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call